Your browser doesn't support javascript.
loading
Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries.
Bochenek, Tomasz; Abilova, Vafa; Alkan, Ali; Asanin, Bogdan; de Miguel Beriain, Iñigo; Besovic, Zeljka; Vella Bonanno, Patricia; Bucsics, Anna; Davidescu, Michal; De Weerdt, Elfi; Duborija-Kovacevic, Natasa; Fürst, Jurij; Gaga, Mina; Gailite, Elma; Gulbinovic, Jolanta; Gürpinar, Emre U; Hankó, Balázs; Hargaden, Vincent; Hotvedt, Tor A; Hoxha, Iris; Huys, Isabelle; Inotai, Andras; Jakupi, Arianit; Jenzer, Helena; Joppi, Roberta; Laius, Ott; Lenormand, Marie-Camille; Makridaki, Despina; Malaj, Admir; Margus, Kertu; Markovic-Pekovic, Vanda; Miljkovic, Nenad; de Miranda, João L; Primozic, Stanislav; Rajinac, Dragana; Schwartz, David G; Sebesta, Robin; Simoens, Steven; Slaby, Juraj; Sovic-Brkicic, Ljiljana; Tesar, Tomas; Tzimis, Leonidas; Warminska, Ewa; Godman, Brian.
Afiliação
  • Bochenek T; Department of Drug Management, Faculty of Health Sciences, Jagiellonian University Medical College, Krakow, Poland.
  • Abilova V; Analytical Expertise Centre, Ministry of Health, Baku, Azerbaijan.
  • Alkan A; Turkish Medicines and Medical Devices Agency, Ankara, Turkey.
  • Asanin B; Department of Surgery, Department of Medical Ethics, Medical Faculty of the University of Montenegro, Podgorica, Montenegro.
  • de Miguel Beriain I; RG Chair in Law and the Human Genome, University of the Basque Country, Leioa, Spain.
  • Besovic Z; Montenegrin Agency for Drugs and Medical Devices, Sector for Drugs and Medical Devices, Podgorica, Montenegro.
  • Vella Bonanno P; Department of Pharmacoepidemiology, Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom.
  • Bucsics A; Mechanism of Coordinated Access to Orphan Medicinal Products, Brussels, Belgium.
  • Davidescu M; Clalit Health Services Headquarters, Tel-Aviv, Israel.
  • De Weerdt E; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Duborija-Kovacevic N; Department of Pharmacology and Clinical Pharmacology, Medical Faculty of the University of Montenegro, Podgorica, Montenegro.
  • Fürst J; Department of Medicines, Health Insurance Institute, Ljubljana, Slovenia.
  • Gaga M; 7th Respiratory Medicine Department, Athens Chest Hospital Sotiria, Athens, Greece.
  • Gailite E; State Agency of Medicines, Riga, Latvia.
  • Gulbinovic J; Department of Pathology, Forensic Medicine and Pharmacology, Vilnius University, Vilnius, Lithuania.
  • Gürpinar EU; State Medicine Control Agency, Vilnius, Lithuania.
  • Hankó B; Turkish Medicines and Medical Devices Agency, Ankara, Turkey.
  • Hargaden V; University Pharmacy Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary.
  • Hotvedt TA; School of Mechanical and Materials Engineering, University College Dublin, Dublin, Ireland.
  • Hoxha I; Norwegian Medicines Agency, Oslo, Norway.
  • Huys I; Department of Pharmacy, University of Medicine, Tirana, Albania.
  • Inotai A; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
  • Jakupi A; Syreon Research Institute, Budapest, Hungary.
  • Jenzer H; Department of Health Policy and Health Economics, Institute of Economics, Eötvös Loránd University, Budapest, Hungary.
  • Joppi R; Department of Drug Management, Faculty of Pharmacy, UBT (Kosovo), Prishtina, Albania.
  • Laius O; Health Department, Bern University of Applied Sciences, Bern, Switzerland.
  • Lenormand MC; University Hospital of Psychiatry Zurich (PUK), Zurich, Switzerland.
  • Makridaki D; Local Health Unit of Verona-Veneto Region, Verona, Italy.
  • Malaj A; State Agency of Medicines, Tartu, Estonia.
  • Margus K; CNAMTS, Statutory Health Insurance for Salaried Workers, Paris, France.
  • Markovic-Pekovic V; Panhellenic Association of Hospital Pharmacists, Athens, Greece.
  • Miljkovic N; National Organization for Medicines, Athens, Greece.
  • de Miranda JL; Department of Pharmacy, University of Medicine, Tirana, Albania.
  • Primozic S; Estonian State Agency of Medicines, Tartu, Estonia.
  • Rajinac D; Ministry of Health and Social Welfare, Banja Luka, Republic of Srpska, Bosnia and Herzegovina.
  • Schwartz DG; Faculty of Medicine, Department of Social Pharmacy, University of Banja Luka (Republic of Srpska), Banja Luka, Bosnia and Herzegovina.
  • Sebesta R; Institute of Orthopaedic Surgery Banjica, Belgrade, Serbia.
  • Simoens S; Escola Superior de Tecnologia e Gestão, Instituto Politécnico de Portalegre, Portalegre, Portugal.
  • Slaby J; Centro de Recursos Naturais e Ambiente, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, Portugal.
  • Sovic-Brkicic L; Agency for Medicinal Products and Medicinal Devices, Ljubljana, Slovenia.
  • Tesar T; Clinical Centre of Serbia, Belgrade, Serbia.
  • Tzimis L; Graduate School of Business Administration, Bar-Ilan University, Ramat-Gan, Israel.
  • Warminska E; State Institute for Drug Control, Prague, Czechia.
  • Godman B; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Front Pharmacol ; 8: 942, 2017.
Article em En | MEDLINE | ID: mdl-29403372
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article